Expertise in
33
conditions

Dr. George J. Schmieder

Park Avenue Dermatology PA
Orange Park, FL
Expertise in
33
conditions
Specialties:Dermatology
Accepting New Patients
Expertise in
33
conditions
OverviewInsuranceLocationsClinical Research

Overview

George Schmieder is a Dermatologist in Orange Park, Florida. Do. Schmieder is highly rated in 33 conditions, according to our data. His top areas of expertise are Actinic Keratosis, Psoriasis, Plaque Psoriasis, and Squamous Cell Skin Carcinoma. Do. Schmieder is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in FL
Languages Spoken
English
Spanish
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Health Options
  •  UnitedHealthcare
  •  Humana
  •  Florida Blue

Locations

PARK AVENUE DERMATOLOGY PA
906 Park Ave, Orange Park, FL 32073
904-541-0315

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Active_not_recruiting
Publish Date: January 23, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Drug
Study Drug: QTORIN rapamycin anhydrous gel
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Active- and Vehicle-Controlled Study to Compare the Efficacy and Safety of Products S2G6T-1, S2G6T-2, S2G6T-3 and S2G6T-4 in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
A Randomized, Double-Blind, Active- and Vehicle-Controlled Study to Compare the Efficacy and Safety of Products S2G6T-1, S2G6T-2, S2G6T-3 and S2G6T-4 in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Enrollment Status: Terminated
Publish Date: November 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
Enrollment Status: Completed
Publish Date: February 15, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: December 13, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

5 Total Publications

The Molting Man: Anasarca-Induced Full-Body Desquamation.
The Molting Man: Anasarca-Induced Full-Body Desquamation.
Journal: Cutis
Published: June 06, 2022
Similar Doctors
Expertise in
31
conditions
Dr. Josep Genebriera-De
Dermatology
Expertise in
31
conditions
Dr. Josep Genebriera-De
Dermatology

Advanced Dermatology And Cosmetic Surgery

1639 Atlantic Blvd, 
Jacksonville, FL 
 (9.3 mi)
866-400-3376
Languages Spoken:
English, Catalan, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Josep Genebriera-De is a Dermatologist in Jacksonville, Florida. Dr. Genebriera-De is highly rated in 31 conditions, according to our data. His top areas of expertise are Generalized Pustular Psoriasis (GPP), Pustular Psoriasis, Kaposiform Hemangioendothelioma, and Hemangioendothelioma. Dr. Genebriera-De is currently accepting new patients.

Expertise in
13
conditions
Dr. Jonathan Kantor
Dermatology
Expertise in
13
conditions
Dr. Jonathan Kantor
Dermatology
1301 Plantation Island Dr S, Suite 106b, 
St Augustine, FL 
 (32.6 mi)
904-342-7765
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jonathan Kantor is a Dermatologist in St Augustine, Florida. Dr. Kantor is highly rated in 13 conditions, according to our data. His top areas of expertise are Familial Atypical Multiple Mole Melanoma Syndrome, Basal Cell Skin Cancer, Syringoma, and Sebaceous Adenoma. Dr. Kantor is currently accepting new patients.

Expertise in
29
conditions
Dr. Kiran Motaparthi
Dermatology
Expertise in
29
conditions
Dr. Kiran Motaparthi
Dermatology

Florida Clinical Practice Association Inc

2000 Sw Archer Rd, Uf Health Congenital Heart Center Medical, 
Gainesville, FL 
 (53.8 mi)
352-265-8250
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kiran Motaparthi is a Dermatologist in Gainesville, Florida. Dr. Motaparthi is highly rated in 29 conditions, according to our data. His top areas of expertise are Pemphigus, Pemphigus Foliaceus, Pemphigus Vulgaris, Cicatricial Pemphigoid, and Penectomy. Dr. Motaparthi is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile